APA

Barra M. E., Das A. S., Hayes B. D., Rosenthal E. S., Rosovsky R. P., Fuh L., Patel A. B., Goldstein J. N. & Roberts R. J. (20210514). Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages. : Journal of thrombosis and haemostasis : JTH.

Chicago

Barra Megan E, Das Alvin S, Hayes Bryan D, Rosenthal Eric S, Rosovsky Rachel P, Fuh Lanting, Patel Aman B, Goldstein Joshua N and Roberts Russel J. 20210514. Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages. : Journal of thrombosis and haemostasis : JTH.

Harvard

Barra M. E., Das A. S., Hayes B. D., Rosenthal E. S., Rosovsky R. P., Fuh L., Patel A. B., Goldstein J. N. and Roberts R. J. (20210514). Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages. : Journal of thrombosis and haemostasis : JTH.

MLA

Barra Megan E, Das Alvin S, Hayes Bryan D, Rosenthal Eric S, Rosovsky Rachel P, Fuh Lanting, Patel Aman B, Goldstein Joshua N and Roberts Russel J. Evaluation of andexanet alfa and four-factor prothrombin complex concentrate (4F-PCC) for reversal of rivaroxaban- and apixaban-associated intracranial hemorrhages. : Journal of thrombosis and haemostasis : JTH. 20210514.